Published in J Neurosci on August 28, 2013
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression. Cell (2015) 3.03
Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma. Neuro Oncol (2014) 1.53
PD-L1 and Survival in Solid Tumors: A Meta-Analysis. PLoS One (2015) 1.45
PD-L1 expression and prognostic impact in glioblastoma. Neuro Oncol (2015) 1.16
Immunotherapy for brain cancer: recent progress and future promise. Clin Cancer Res (2014) 0.99
Immune checkpoint inhibitors in clinical trials. Chin J Cancer (2014) 0.98
Lack of Neuronal IFN-β-IFNAR Causes Lewy Body- and Parkinson's Disease-like Dementia. Cell (2015) 0.96
MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints. Neuro Oncol (2015) 0.89
Prognostic significance of programmed death-1 and programmed death-ligand 1 expression in patients with esophageal squamous cell carcinoma. Oncotarget (2016) 0.87
Immunosuppressive mechanisms in glioblastoma. Neuro Oncol (2015) 0.84
Neuro-oncology: Glioblastoma prognosis linked to neuronal PD-L1 expression in tumour-adjacent tissue. Nat Rev Neurol (2013) 0.82
Expression of programmed cell death-ligand 1 and its correlation with clinical outcomes in gliomas. Oncotarget (2016) 0.82
Clinical Neuropathology mini-review 6-2015: PD-L1: emerging biomarker in glioblastoma? Clin Neuropathol (2015) 0.82
Alerting the immune system via stromal cells is central to the prevention of tumor growth. Oncoimmunology (2013) 0.80
Cytomegalovirus as a novel target for immunotherapy of glioblastoma multiforme. Front Oncol (2014) 0.79
Immunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS Sites. Front Oncol (2015) 0.79
Endogenous IFN-β signaling exerts anti-inflammatory actions in experimentally induced focal cerebral ischemia. J Neuroinflammation (2015) 0.79
Recent advances and future of immunotherapy for glioblastoma. Expert Opin Biol Ther (2016) 0.77
Blocking the PD-1/PD-L1 pathway in glioma: a potential new treatment strategy. J Hematol Oncol (2017) 0.75
Neuronal IFN-beta-induced PI3K/Akt-FoxA1 signalling is essential for generation of FoxA1(+)Treg cells. Nat Commun (2017) 0.75
Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives. Biomed Res Int (2017) 0.75
Targeting immune checkpoints in malignant glioma. Oncotarget (2016) 0.75
Autocrine activation of the IFN signaling pathway may promote immune escape in glioblastoma. Neuro Oncol (2017) 0.75
PD-L1 and intratumoral immune response in breast cancer. Oncotarget (2017) 0.75
Assessment of PD-1 positive cells on initial and secondary resected tumor specimens of newly diagnosed glioblastoma and its implications on patient outcome. J Neurooncol (2017) 0.75
Chemotherapy induces tumor immune evasion by upregulation of programmed cell death ligand 1 expression in bone marrow stromal cells. Mol Oncol (2017) 0.75
Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE. Nat Med (2006) 2.94
Dual effects of vitamin D-induced alteration of TH1/TH2 cytokine expression: enhancing IgE production and decreasing airway eosinophilia in murine allergic airway disease. J Allergy Clin Immunol (2003) 2.22
Long-term mobile phone use and acoustic neuroma risk. Epidemiology (2014) 2.01
Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target. J Clin Invest (2011) 1.87
IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis. J Immunol (2003) 1.68
Bone marrow multipotent mesenchymal stroma cells act as pericyte-like migratory vehicles in experimental gliomas. Mol Ther (2008) 1.61
The immunobiology of aluminium adjuvants: how do they really work? Trends Immunol (2010) 1.45
What has inflammation to do with traumatic brain injury? Childs Nerv Syst (2009) 1.26
GABA, a natural immunomodulator of T lymphocytes. J Neuroimmunol (2008) 1.24
Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapy. Cancer Immunol Immunother (2008) 1.18
IFN-beta inhibits T cell activation capacity of central nervous system APCs. J Immunol (2006) 1.12
Stromal cells and osteoclasts are responsible for exacerbated collagen-induced arthritis in interferon-beta-deficient mice. Arthritis Rheum (2005) 1.10
Clinical experience with the use of a shunt with an adjustable valve in children with hydrocephalus. J Neurosurg (2003) 1.00
Glycosylation of type II collagen is of major importance for T cell tolerance and pathology in collagen-induced arthritis. Eur J Immunol (2002) 1.00
Inhibition of CXCL12 signaling attenuates the postischemic immune response and improves functional recovery after stroke. J Cereb Blood Flow Metab (2013) 0.99
Recruited brain tumor-derived mesenchymal stem cells contribute to brain tumor progression. Stem Cells (2014) 0.99
Absence of Epstein-Barr and cytomegalovirus infection in neuroblastoma cells by standard detection methodologies. Pediatr Blood Cancer (2013) 0.98
IFNB1/interferon-β-induced autophagy in MCF-7 breast cancer cells counteracts its proapoptotic function. Autophagy (2013) 0.97
LEPREL1, a novel ER and Golgi resident member of the Leprecan family. Biochem Biophys Res Commun (2004) 0.96
Cure of established GL261 mouse gliomas after combined immunotherapy with GM-CSF and IFNgamma is mediated by both CD8+ and CD4+ T-cells. Int J Cancer (2009) 0.92
Induction of endogenous Type I interferon within the central nervous system plays a protective role in experimental autoimmune encephalomyelitis. Acta Neuropathol (2015) 0.91
Smad7 in T cells drives T helper 1 responses in multiple sclerosis and experimental autoimmune encephalomyelitis. Brain (2010) 0.91
Upregulation of B7 molecules (CD80 and CD86) and exacerbated eosinophilic pulmonary inflammatory response in mice lacking the IFN-beta gene. J Allergy Clin Immunol (2003) 0.90
CD1d-dependent NKT cells play a protective role in acute and chronic arthritis models by ameliorating antigen-specific Th1 responses. J Immunol (2010) 0.90
A novel T cell receptor transgenic animal model of seborrheic dermatitis-like skin disease. J Invest Dermatol (2005) 0.89
Endogenous collagen peptide activation of CD1d-restricted NKT cells ameliorates tissue-specific inflammation in mice. J Clin Invest (2010) 0.88
Identification and characterization of a human smad3 splicing variant lacking part of the linker region. Gene (2004) 0.88
Identification of proteins involved in neural progenitor cell targeting of gliomas. BMC Cancer (2009) 0.87
CD133+ and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomas. Int J Cancer (2009) 0.87
Immunizations with IFNgamma secreting tumor cells can eliminate fully established and invasive rat gliomas. J Immunother (2009) 0.87
The outermost N-terminal region of tapasin facilitates folding of major histocompatibility complex class I. Eur J Immunol (2009) 0.85
CD1-dependent regulation of chronic central nervous system inflammation in experimental autoimmune encephalomyelitis. J Immunol (2004) 0.85
Preoperative vestibular ablation with gentamicin and vestibular 'prehab' enhance postoperative recovery after surgery for pontine angle tumours--first report. Acta Otolaryngol (2007) 0.84
Intratumoral IL-7 delivery by mesenchymal stromal cells potentiates IFNgamma-transduced tumor cell immunotherapy of experimental glioma. J Neuroimmunol (2009) 0.83
Synergism between GM-CSF and IFNgamma: enhanced immunotherapy in mice with glioma. Int J Cancer (2007) 0.83
Intratumoral COX-2 inhibition enhances GM-CSF immunotherapy against established mouse GL261 brain tumors. Int J Cancer (2013) 0.83
Aluminium based adjuvants and their effects on mitochondria and lysosomes of phagocytosing cells. J Inorg Biochem (2013) 0.82
Inhibition of cyclooxygenase-2 enhances immunotherapy against experimental brain tumors. Cancer Immunol Immunother (2012) 0.81
Role of tobacco use in the etiology of acoustic neuroma. Am J Epidemiol (2012) 0.81
Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion. Cancer Immunol Immunother (2013) 0.81
Rat multipotent mesenchymal stromal cells lack long-distance tropism to 3 different rat glioma models. Neurosurgery (2012) 0.81
IFNγ in combination with IL-7 enhances immunotherapy in two rat glioma models. J Neuroimmunol (2013) 0.80
Postimmunization with IFN-gamma-secreting glioma cells combined with the inducible nitric oxide synthase inhibitor mercaptoethylguanidine prolongs survival of rats with intracerebral tumors. J Immunol (2007) 0.80
The dual role of nitric oxide in glioma. Curr Pharm Des (2010) 0.80
Local therapy with CpG motifs in a murine model of allergic airway inflammation in IFN-beta knock-out mice. Respir Res (2005) 0.79
Suppression of EAE by oral tolerance is independent of endogenous IFN-beta whereas treatment with recombinant IFN-beta ameliorates EAE. Immunol Cell Biol (2010) 0.79
Impact on allergic immune response after treatment with vitamin A. Nutr Metab (Lond) (2009) 0.79
Similar response in male and female B10.RIII mice in a murine model of allergic airway inflammation. Inflamm Res (2009) 0.79
Aberrant immunostaining pattern of the CD24 glycoprotein in clinical samples and experimental models of pediatric medulloblastomas. J Neurooncol (2015) 0.78
Peptides modeled after the alpha-domain of metallothionein induce neurite outgrowth and promote survival of cerebellar granule neurons. Eur J Cell Biol (2009) 0.78
Antiinflammatory properties of a peptide derived from interleukin-4. Cytokine (2013) 0.78
Intrinsic tolerance in autologous collagen-induced arthritis is generated by CD152-dependent CD4+ suppressor cells. J Immunol (2005) 0.77
Loud noise exposure and acoustic neuroma. Am J Epidemiol (2014) 0.77
Vestibular "PREHAB". Ann N Y Acad Sci (2009) 0.77
Deficient Fas expression by CD4+ CCR5+ T cells in multiple sclerosis. J Neuroimmunol (2006) 0.77
A loss-of-function screen for phosphatases that regulate neurite outgrowth identifies PTPN12 as a negative regulator of TrkB tyrosine phosphorylation. PLoS One (2013) 0.77
Activation of purified allogeneic CD4(+) T cells by rat bone marrow-derived dendritic cells induces concurrent secretion of IFN-gamma, IL-4, and IL-10. Immunol Lett (2005) 0.77
Reversal of tolerance induced by transplantation of skin expressing the immunodominant T cell epitope of rat type II collagen entitles development of collagen-induced arthritis but not graft rejection. Eur J Immunol (2002) 0.76
Enhanced expression of iNOS intratumorally and at the immunization site after immunization with IFNgamma-secreting rat glioma cells. J Neuroimmunol (2002) 0.76
Is there a benefit of using artificial cerebrospinal fluid for irrigation? World Neurosurg (2011) 0.75
Pituitary disease mortality: is it fiction? Pituitary (2013) 0.75
Corrigendum: Neuronal IFN-beta-induced PI3K/Akt-FoxA1 signalling is essential for generation of FoxA1(+)Treg cells. Nat Commun (2017) 0.75
Hearing and Vestibular Function After Preoperative Intratympanic Gentamicin Therapy for Vestibular Schwanomma as Part of Vestibular Prehab. Ear Hear (2016) 0.75
HLA-I antigen presentation and tapasin influence immune responses against malignant brain tumors - considerations for successful immunotherapy. Anticancer Agents Med Chem (2014) 0.75